Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders (Q34756564)

4 August 2017

1 reference

title

Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders (English)

1 reference

4 August 2017

0 references

Keow G Sim

1

1 reference

PubMed ID

12135806

4 August 2017

Judith Hammond

series ordinal

2

1 reference

PubMed ID

12135806

4 August 2017

Bridget Wilcken

series ordinal

3

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

323

1 reference

4 August 2017

37-58

1 reference

4 August 2017

1-2

1 reference

Myocardial utilization of carbohydrate and lipids

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Molecular mechanism of cellular uptake and intracellular translocation of fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Mechanisms of cellular uptake of long chain free fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A family of fatty acid transporters conserved from mycobacterium to man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Co-expression in rat heart and skeletal muscle of four genes coding for proteins implicated in long-chain fatty acid uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fatty acid transporters (FABPpm, FAT, FATP) in human muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Activation of free fatty acids in subcellular fractions of human skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Intracellular transport of fatty acids in muscle. Role of cytoplasmic fatty acid-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Ligand specificity and conformational stability of human fatty acid-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fatty acid import into mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Mammalian mitochondrial beta-oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Structural analysis of cDNAs for subunits of human mitochondrial fatty acid beta-oxidation trifunctional protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Disorders of mitochondrial fatty acyl-CoA beta-oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Regulation of hepatic fatty acid oxidation and ketone body production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Recognition and management of fatty acid oxidation defects: a series of 107 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Disorders of mitochondrial long-chain fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Defects in activation and transport of fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Inborn errors of mitochondrial fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Dissecting the spectrum of fatty acid oxidation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Metabolic disease and sudden, unexpected death in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Medium chain acyl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

7 January 2021

Mitochondrial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Application of electrospray tandem mass spectrometry to neonatal screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

The HELLP syndrome associated wiht fetal medium-chain acyl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Hypoparathyroidism in mitochondrial trifunctional protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Muscle cytochrome c oxidase deficiency accompanied by a urinary organic acid pattern mimicking multiple acyl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Mitochondrial respiratory chain complex I deficiency with clinical and biochemical features of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Genetic basis of mitochondrial HMG-CoA synthase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A defect in the transport of long-chain fatty acids associated with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Quantitative analysis of urinary acylglycines for the diagnosis of β-oxidation defects using GC-NCI-MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Screening for fatty acid beta oxidation disorders. Acylglycine analysis by electron impact ionization gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Plasma free fatty acids in mitochondrial fatty acid oxidation defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Impaired fatty acid oxidation in propofol infusion syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Genomics of the human carnitine acyltransferase genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Acquired carnitine abnormalities in critically ill children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

14C-labeled substrate catabolism by human diploid fibroblasts derived from infants and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Differential diagnosis of hydroxydicarboxylic aciduria based on release of3H2O from [9,10‐3H]myristic and [9,10‐3H]palmitic acids by intact cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Impaired mitochondrial fatty acid oxidative flux in fibroblasts from a patient with malonyl-CoA decarboxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Evidence for intermediate channeling in mitochondrial beta-oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Recent developments in the investigation of inherited metabolic disorders using cultured human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Cytochrome C oxidase deficiency and Long‐Chain acyl coenzyme A dehydrogenase deficiency with Leigh's subacute necrotizing encephalomyelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Pathology of skeletal muscle and impaired respiratory chain function in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency with the G1528C mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: possible diagnostic pitfalls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Isolation and characterization of cDNA and genomic clones encoding human muscle type carnitine palmitoyltransferase I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that res

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Carnitine palmitoyltransferase II deficiency: diagnosis by molecular analysis of blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Common MCAD mutation in a healthy parent of two affected siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Liver disease in pregnancy and fetal fatty acid oxidation defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Carnitine palmitoyltransferase deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Inheritance of the S113L mutation within an inbred family with carnitine palmitoyltransferase enzyme deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Elucidation of the mechanism by which (+)-acylcarnitines inhibit mitochondrial fatty acid transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Multiple acyl-CoA-dehydrogenase deficiency (MADD): use of acylcarnitines and fatty acids to monitor the response to dietary treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900182-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(02)00182-1

1 reference

4 August 2017

1 reference

PubMed ID

12135806